5.870USD0.00%Mkt Cap: 566.16M USDP/E: —Last update: 2026-06-01
Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfe…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap566.16M USD
Enterprise Value526.70M USD
Revenue (TTM)117.05M USD
Gross Profit111.17M USD
Net Income (TTM)5.03M USD
Revenue/Share1.292 USD
Last Price5.870 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees625
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)98.50
PEG—
EV/EBITDA103.82
EV/Revenue4.50
P/S4.90
P/B5.33
EPS (TTM)-0.08
EPS (Forward)0.06
52W Range
5.6705% of range9.780
52W High9.780 USD
52W Low5.670 USD
Profitability
Gross Margin95.35%
Oper. Margin-30.21%
EBITDA Margin4.33%
Profit Margin4.31%
ROE4.74%
ROA3.03%
Growth
Revenue Growth2.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF1.01M USD
CapEx (TTM)1.92M USD
FCF Margin8.20%
FCF Yield1.70%
Net Debt-48.98M USD
Net Debt/EBITDA-9.66
Balance Sheet
Debt/Equity0.01
Current Ratio4.64
Quick Ratio3.68
Book Value/Sh1.109 USD
Cash/Share0.5450 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJan 12, 2023
Splits
Last Split1:15
Split DateOct 31, 2023
Analyst Consensus
Rating—
Target (Mean)18.67 USD
Target Range18.00 USD – 20.00 USD
# Analysts3
Ownership
Shares Out.97.03M
Float21.28M
Insiders86.33%
Institutions3.75%
Short Interest
Short Ratio23.8d
Short % Float8.08%
Short % Out.1.73%
Shares Short1.68M
Short (prev mo.)1.58M
Technical
SMA 507.156 (-18.0%)
SMA 2007.638 (-23.1%)
Beta5.28
S&P 52W Chg27.94%
Avg Vol (30d)75.54K
Avg Vol (10d)105.82K
Technical Indicators
RSI (14)32.5
MACD-0.4506
MACD Signal-0.3511
MACD Hist.-0.0995
BB Upper8.331 USD
BB Middle6.790 USD
BB Lower5.249 USD
BB Width45.39%
ATR (14)0.3250 USD
Vol Ratio (20d)0.51x